Trading in Elicera Therapeutics AB paid subscription units is to cease. The last trading day is March 28, 2024. Short name: ELIC BTU ISIN code: SE0021626306 Orderbook ID: 324876 This information is distributed at the request of the Certified Adviser, Carnegie Investment Bank AB (publ). For further information, please call Carnegie Investment Bank AB (publ) on 08-588 68 570.
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Elicera Therapeutics presents first clinical results from iTANK-armed CAR T-cell therapy at scientific conference | ||
| 15.01. | ELICERA THERAPEUTICS: Elicera's candidate ELC-100 granted Orphan Drug Designation | ||
| 13.01. | Elicera Therapeutics' drug candidate ELC-100 receives Orphan Drug Designation in the U.S. for the treatment of pancreatic neuroendocrine tumors | ||
| 28.11.24 | Elicera Therapeutics AB: Elicera Therapeutics AB (publ) Interim Report 1 January - 30 September 2024 | Third quarter (July-September 2024)
Operating profit/loss amounted to SEK -2,697,267 (-5,149,440).
Loss for the period amounted to SEK -2,514,629 (-5,046,574).
Cash flow from operating activities... ► Artikel lesen | |
| 27.11.24 | ELICERA THERAPEUTICS: Elicera's CEO: "ELC-100 stands apart from all other standard treatments" |
